Biology Reference
In-Depth Information
Dar AA, Goff LW, Majid S, Berlin J, El-Rifai W (2010) Aurora kinase inhibitors-rising stars in
cancer therapeutics? Mol Cancer Ther 9:268-278
Date O, Katsura M, Ishida M, Yoshihara T, Kinomura A, Sueda T, Miyagawa K (2006)
Haploinsufficiency of RAD51B causes centrosome fragmentation and aneuploidy in human
cells. Cancer Res 66:6018-6024
Dementyeva E, Nemec P, Kryukov F (2010) Centrosome amplification as a possible marker of
mitotic disruptions and cellular carcinogenesis in multiple myeloma. Leuk Res 34:1007-1011
Dib A, Peterson TR, Raducha-Grace L, Zingone A, Zhan F, Hanamura I, Barlogie B,
Shaughnessy J Jr, Kuehl WM (2006) Paradoxical expression of INK4c in proliferative
multiple myeloma tumors: bi-allelic deletion vs increased expression. Cell Div 1:23
Dib A, Barlogie B, Shaughnessy JD Jr, Kuehl WM (2007) Methylation and expression of the
p16INK4A tumor suppressor gene in multiple myeloma. Blood 109:1337-1338
Dickens NJ, Walker BA, Leone PE, Johnson DC, Brito JL, Zeisig A, Jenner MW, Boyd KD,
Gonzalez D, Gregory WM, Ross FM, Davies FE, Morgan GJ (2010) Homozygous deletion
mapping in myeloma samples identifies genes and an expression signature relevant to
pathogenesis and outcome. Clin Cancer Res 16:1856-1864
Drach J, Schuster J, Nowotny H, Angerler J, Rosenthal F, Fiegl M, Rothermundt C, Gsur A, Jager
U, Heinz R et al (1995) Multiple myeloma: high incidence of chromosomal aneuploidy as
detected by interphase fluorescence in situ hybridization. Cancer Res 55:3854-3859
Duensing S, Lee LY, Duensing A, Basile J, Piboonniyom S, Gonzalez S, Crum CP, Munger K
(2000) The human papillomavirus type 16 E6 and E7 oncoproteins cooperate to induce
mitotic defects and genomic instability by uncoupling centrosome duplication from the cell
division cycle. Proc Natl Acad Sci U S A 97:10002-10007
Dutertre S, Descamps S, Prigent C (2002) On the role of aurora-A in centrosome function.
Oncogene 21:6175-6183
Dutta-Simmons J, Zhang Y, Gorgun G, Gatt M, Mani M, Hideshima T, Takada K, Carlson NE,
Carrasco DE, Tai YT, Raje N, Letai AG, Anderson KC, Carrasco DR (2009) Aurora kinase A is a target
of Wnt/beta-catenin involved in multiple myeloma disease progression. Blood 114:2699-2708
Elnenaei MO, Gruszka-Westwood AM, A'Hernt R, Matutes E, Sirohi B, Powles R, Catovsky D
(2003) Gene abnormalities in multiple myeloma; the relevance of TP53, MDM2, and
CDKN2A. Haematologica 88:529-537
Ely S, Di Liberto M, Niesvizky R, Baughn LB, Cho HJ, Hatada EN, Knowles DM, Lane J, Chen-
Kiang S (2005) Mutually exclusive cyclin-dependent kinase 4/cyclin D1 and cyclin-
dependent kinase 6/cyclin D2 pairing inactivates retinoblastoma protein and promotes cell
cycle dysregulation in multiple myeloma. Cancer Res 65:11345-11353
Errabolu R, Sanders MA, Salisbury JL (1994) Cloning of a cDNA encoding human centrin, an
EF-hand protein of centrosomes and mitotic spindle poles. J Cell Sci 107(Pt 1):9-16
Evans R, Naber C, Steffler T, Checkland T, Keats J, Maxwell C, Perry T, Chau H, Belch A, Pilarski L,
Reiman T (2008) Aurora A kinase RNAi and small molecule inhibition of Aurora kinases with VE-
465 induce apoptotic death in multiple myeloma cells. Leuk Lymphoma 49:559-569
Fielding AB, Lim S, Montgomery K, Dobreva I, Dedhar S (2011) A critical role of integrin-linked
kinase, ch-TOG and TACC3 in centrosome clustering in cancer cells. Oncogene 30:521-534
Filipits M, Pohl G, Stranzl T, Kaufmann H, Ackermann J, Gisslinger H, Greinix H, Chott A,
Drach J (2003) Low p27Kip1 expression is an independent adverse prognostic factor in
patients with multiple myeloma. Clin Cancer Res 9:820-826
Fisk HA, Winey M (2001) The mouse Mps1p-like kinase regulates centrosome duplication. Cell
106:95-104
Fonseca R, Debes-Marun CS, Picken EB, Dewald GW, Bryant SC, Winkler JM, Blood E, Oken
MM, Santana-Davila R, Gonzalez-Paz N, Kyle RA, Gertz MA, Dispenzieri A, Lacy MQ,
Greipp PR (2003a) The recurrent IgH translocations are highly associated with nonhyper-
diploid variant multiple myeloma. Blood 102:2562-2567
Fonseca R, Blood E, Rue M, Harrington D, Oken MM, Kyle RA, Dewald GW, Van Ness B, Van
Wier SA, Henderson KJ, Bailey RJ, Greipp PR (2003b) Clinical and biologic implications of
recurrent genomic aberrations in myeloma. Blood 101:4569-4575
